Back

New society guidance: which patients are likely to benefit from renal denervation?

27 August 2022 (10:32 - 10:40)
Organised by:
Congress Presentation Part of: Reducing cardiovascular events in hypertensive patients: new treatment options Renal Denervation Open Access ESC Congress 2022

About the speaker

Photo
Professor Roland Schmieder

University Hospital Erlangen, Erlangen (Germany)

5 More presentations in this session

Presentation thumbnail
Introduction.
Professor M. Boehm (Homburg, DE)
Slides Video
Presentation thumbnail
Can renal denervation reduce cardiovasculer events?
Professor F. Mahfoud (Basel, CH)
Slides Video
Presentation thumbnail
Cased-based discussion: patients intolerant to medications.
Professor S. Brouwers (Aalst, BE)
Slides Video
Presentation thumbnail
Cased-based discussion: high CV risk patients.
Doctor O. Rodriguez Leor (Barcelona, ES)
Slides Video
Presentation thumbnail
Discussion.
Professor A. Pathak (Luxembourg, LU)
Slides Video

Access the full session

Session thumbnail
Reducing cardiovascular events in hypertensive patients: new treatment options
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 10:32 CET
You may be interested in
thumbnail
Congress Presentation
Renal denervation: what do the guidelines and consensus statements recommend?
26 August 2023
thumbnail
Congress Session
Guidelines in Practice: 2024 ESC Clinical Practice Guidelines - how do I apply them in my daily practice?
30 August 2025
thumbnail
Congress Presentation
How do I manage refractory hypertension?
1 September 2024
thumbnail
Congress Presentation
Hypertension: Gaps in evidence
24 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources